TB R & D Report 2005-2009 - Second Edition
By Eleonora Jimenez
March 2011 - This is the 2nd Edition of the Stop TB Partnership and Treatment Action Group’s 2010 report on funding trends for tuberculosis (TB) research and development (R&D) from the baseline year 2005 through 2009, the last year for which full data is available. Updates to this report include new and corrected information from product development partnerships (PDPs) such as Aeras, FIND, TB Alliance, TBVAC and TBVI, as well as revised data from the German Federal Ministry of Education and Research (BMBF).
With five years of comprehensive data,Tuberculosis Research and Development: 2010 Report on Tuberculosis Research Funding trends, 2005-2009 documents global progress against funding targets set by the Stop TB Partnership in 2006 in the Global Plan to Stop TB: 2006-2015, a 10 year implementation and research strategy to eliminate TB as a global health threat by 2050. Across six R&D areas, the report offers year-on-year funding trends, and a comprehensive analysis of the top ten funders for 2009. This year’s report includes data from 94 funders representing 25 countries.
With the launch of the new Global Plan to Stop TB: 2011-2015, the Stop TB Partnership’s funding targets are now aligned with TAG’s recommended USD$2 billion per year needed to develop new tools to prevent, diagnose, and treat TB. Furthermore, the revised Global Plan includes funding targets for fundamental science and operational research--two key research areas necessary for the development of new tools and evaluation of their effective implementation in programmatic settings. This report shows that despite a 73% increase in resources invested in TB R&D from 2005-2009, the funding available falls far short of the USD$2 billion.